Carboxyl-functionalized upconverting nanoparticles - Em. Wavelength:804 nm,particle size:35nm,Coating:dSiO2-COOH

Cat. No.: C140949
AVAILABLE TO ORDER
GRADE & PURITY Em. Wavelength:804 nm,particle size:35nm,Coating:dSiO2-COOH
Storage
Room temperature
Shipped In
Normal
★
Size
Germany (EU)
USA*
Price
Qty
10mg
C140949-10mg
Made to order · 8–12 wks

€1,655.56

€1,931.50
Save €275.94 (14.29%)
Enter a quantity for the sizes you want to add.

Overview

This series of products contains amino functionalized NaYREF4 (RE:Yb, Er, Tm, Gd, Mn, Lu) UCNs with optimal excitation wavelength at 975 nm. The sensitizer is Yb3+, and the activator is Er3+ or Tm3+. The doping concentrations are optimized, leading to strong upconverted emissions at specific wavelengths.The nanoparticles are highly hydrophilic due to the silica coating or PEG coating. The UCNs are of high quantum efficiency and very photostable
After proper surface modification and functionalization, the products can be used for fluorescence imaging, biodetection, immunity analysis and photoactivation of anti-cancer drugs and biomolecules.

Specifications

Specifications & Purity
Em. Wavelength:804 nm,particle size:35nm,Coating:dSiO2-COOH
Storage
Room temperature
Shipped In
Normal

Advanced Data

Certificates (CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Solution Calculators
Reviews

Customer Reviews

Application Protocols

Item-specific, validated protocols are Not specified for this SKU. The following are general, literature-based procedures to help plan experiments.

  • A. Dispersion and quality check

    • Gently resuspend UCNPs in DI water (or specified buffer) by pipetting and brief bath sonication (1–5 min). Avoid probe sonication unless necessary.
    • Assess colloidal stability by DLS (size/PDI) and zeta potential; record baseline upconversion spectrum under NIR excitation.
  • B. EDC/NHS coupling to an amine-bearing ligand (general)

    1. Buffer exchange UCNPs into MES, pH 5.5 (50–100 mM) via centrifugation/redispersion or desalting column.
    2. Add EDC (e.g., 2–10 mM) and NHS or sulfo-NHS (5–20 mM); incubate 15–30 min at RT with gentle mixing.
    3. Transfer to amine-compatible buffer (phosphate or HEPES, pH 7.4–8.0). Add ligand at appropriate excess. Incubate 1–4 h.
    4. Quench with ethanolamine (10–50 mM) for 10–30 min. Purify by centrifugation (optimize g-force for size) or SEC.
    5. Verify conjugation (FTIR, TNBS assay for residual amines, UV–Vis for dye loading) and recheck DLS/optics.
  • C. Fluorescence readout setup (general)

    • Excite at the appropriate NIR wavelength for your UCNPs (commonly 980 nm; if Nd-doped, 808 nm; not specified for this item). Collect visible/UV emission bands with suitable filters; minimize ambient light.

All parameters above are general guidance only; optimize for your specific formulation and instrument setup.

Biological Roles

This product is a synthetic nanomaterial and does not possess intrinsic biological roles such as enzymes or metabolites.

General research context (literature):

  • Optical transduction: UCNPs provide NIR-excitable, visible/UV emission that enables low-background optical readouts in biological research because tissue autofluorescence and light scattering are reduced at NIR wavelengths.
  • Bioconjugation: Surface –COOH groups support covalent attachment of biomolecules (antibodies, peptides, oligonucleotides) via amide linkage, allowing targeted labeling in vitro.
  • Stability: Inorganic cores (e.g., NaYF4-based) are photostable and resistant to photobleaching compared with organic dyes, aiding long-term imaging and single-particle tracking in cell studies (research use only).
  • Magneto/theranostic hybrids: When combined with magnetic or plasmonic components (core–shell or composites), UCNPs can support multimodal imaging/actuation in research settings, though such features are not specified for this item.

Important limitations:

  • No clinical/diagnostic/therapeutic claims are made. Biological performance (toxicity, uptake, biodistribution) is highly formulation- and dose-dependent and must be established empirically for each application. For this SKU, any biological testing results are Not specified; consult the CoA/Spec Sheet and perform your own validation.
Buffer Applications

Carboxyl-functionalized UCNPs are not classic buffering agents. However, buffer choice critically affects their colloidal stability and the efficiency of EDC/NHS coupling.

  • Item-specific buffer recommendations: Not specified for this item; refer to CoA/Spec Sheet.

General, literature-based guidance:

  • Activation buffer (EDC/NHS):
    • Use MES, 50–100 mM, pH 5.0–6.0 to stabilize O-acylisourea intermediates and avoid competing nucleophiles.
    • Avoid Tris, glycine, or other primary-amine-containing buffers during activation/coupling.
  • Coupling buffer:
    • Transition to phosphate or HEPES, pH 7.2–8.0, for reaction with amine-bearing ligands/biomolecules. Maintain ionic strength as low as compatible with stability (e.g., 10–50 mM) to limit aggregation.
  • Storage/handling buffers:
    • Low-ionic-strength PBS or HEPES at neutral pH can be used post-conjugation; add inert blockers (e.g., 0.01–0.1% Tween-20 or BSA) only if compatible with your assay and after confirming colloidal stability. These additives are not part of this item’s specification.
  • pH/ionic effects:
    • Protonation of –COO− below pH ~4 reduces electrostatic repulsion and can induce aggregation; divalent cations (Ca2+, Mg2+) can bridge carboxylates and destabilize colloids.

Always verify particle size (DLS) and optical output after buffer exchanges. Filter sterilization (0.22–0.45 μm, low-protein-binding) may be used if compatible with particle size and concentration.

Green Alternatives

While UCNPs themselves are inorganic photonic materials, their handling and processing can be optimized for greener practice.

  • Current material (this item): Carboxyl-functionalized UCNPs; specific solvent system/ligand identity Not specified for this item.

  • Greener considerations (literature/general):

    • Prefer aqueous dispersion and coupling (MES/PBS) over anhydrous organic solvents when feasible.
    • Use water-soluble carbodiimides (EDC) instead of DCC/DIC to avoid urea byproducts that require organic extraction.
    • Employ PEGylation or zwitterionic coatings to enhance stability in saline buffers, reducing the need for surfactants.
    • Optimize solid-phase or flow-based washing (e.g., size-exclusion chromatography) to minimize solvent consumption compared with repeated centrifugation/redispersion cycles.
    • Source low-toxicity reducing agents and dyes for FRET partners; avoid heavy-metal-containing quenchers when alternatives exist.

Comparison (general):

  • Aqueous EDC/NHS vs DCC/NHS in DMF/DCM: aqueous route avoids chlorinated solvents and simplifies waste handling.
  • MES buffer vs phosphate with excess salts: MES at minimal ionic strength can maintain stability and reduce salt waste.

Trade-offs: Aqueous systems may lower coupling efficiency for hydrophobic targets; short PEG linkers or amphiphiles can bridge solubility while maintaining greener conditions. Verify performance empirically for your construct.

Pharmaceutical Uses

This product is intended for research use only. No pharmacopoeial status, clinical indication, or therapeutic application is claimed for this SKU.

General formulation/technology context (literature):

  • Excipients/Carriers: Carboxyl-functionalized UCNPs can act as luminescent carriers in preclinical formulation studies for tracking, release visualization, or as assay labels. Such uses require case-by-case safety and compatibility evaluation.
  • Conjugation to biologics: –COOH surfaces enable covalent linkage to proteins/peptides via EDC/NHS chemistry, supporting research on targeted delivery systems. Any GMP or clinical translation considerations are outside the scope here.
  • Regulatory considerations: Nanoparticle excipients face stringent characterization (size, PDI, zeta, composition, leachables). For this SKU, item-specific pharmaceutical compliance information is Not specified.

Manufacturing/analytical notes (general):

  • Processability: Disperse in aqueous buffers; avoid shear or conditions that cause aggregation. Use low-protein-binding plastics/glassware to limit adsorption losses.
  • Analytics: Characterize by DLS, TEM, ICP-OES/MS (lanthanide content), and fluorescence spectroscopy to ensure batch-to-batch consistency in research workflows.

Summary: Use in pharmaceutical research and method development only. For clinical or GMP applications, comprehensive risk assessment, validation, and regulatory filings would be required and are not provided for this item.

Physical Properties

Item-specific physico-chemical specifications (core composition, dopant levels, particle size, polydispersity, surface ligand identity/loading, emission maxima, quantum yield, hydrodynamic diameter, zeta potential, residual solvent, metal impurities) are Not specified for this item; refer to CoA/Spec Sheet.

General/literature properties for carboxyl-functionalized UCNPs (for orientation only):

  • Typical core hosts (literature): β-NaYF4, NaGdF4, NaYF4@NaYF4 shell architectures.
  • Crystallinity (literature): Hexagonal phase favored for higher upconversion efficiency vs cubic.
  • Primary particle size (TEM, literature): ~10–80 nm depending on synthesis; hydrodynamic size larger due to ligands/solvation.
  • Surface functionality (literature): –COOH density varies with ligand (e.g., citrate vs poly(acrylic acid)); impacts zeta potential and coupling capacity.
  • Dispersibility (literature): Carboxylated surfaces are commonly dispersible in water and low-ionic-strength buffers; aggregation may occur at low pH or high ionic strength.
  • Zeta potential (literature): Often negative in neutral water (e.g., −15 to −50 mV), reflecting deprotonated carboxylates; actual value is formulation-dependent.
  • Optics (literature): NIR excitation (e.g., 980 nm via Yb3+) with visible/UV emission bands characteristic of Er3+/Tm3+/Ho3+; spectral positions depend on dopants and host.
  • Thermal/photostability (literature): Inorganic cores are photostable and thermally robust; surface organics may degrade under strong oxidants/UV.

Note: None of the above are specifications for this SKU. Use the item’s CoA/SDS for authoritative values.

Quality & Grades
  • Item-specific grade/purity: Not specified for this item; refer to CoA/Spec Sheet.
  • Typical QC attributes for carboxyl-functionalized UCNPs (general guidance):
    • Composition & phase: Powder XRD to verify host lattice and crystallinity (e.g., β-NaYF4 patterns, literature).
    • Morphology/size: TEM/SEM for primary size and shape; DLS for hydrodynamic diameter and PDI in a defined medium.
    • Surface chemistry: FTIR/XPS/TGA to confirm carboxyl functionalization and estimate ligand density; acid–base titration for –COOH content.
    • Optical performance: Upconversion spectra under defined NIR excitation (e.g., 980 nm), relative emission intensities, and photostability tests.
    • Colloidal stability: Zeta potential and stability over time in water/buffers of specified ionic strength/pH.
    • Residuals/contaminants: Solvent and surfactant residues (e.g., TOPO/oleic acid) and trace metal impurities by ICP-OES/MS.
  • What “carboxyl-functionalized” implies (general):
    • Readiness for EDC/NHS coupling to primary amines (proteins, peptides, polymers) and improved aqueous dispersibility versus hydrophobic oleate-capped UCNPs.
  • Documentation: For this SKU, any specifications (size range, emission profile, ligand identity, concentration) are Not specified here; please consult the product’s CoA/Spec Sheet for definitive quality attributes and acceptance criteria.
Reaction & Applications
  • Scope (materials/analytical, literature): Carboxyl-functionalized UCNPs serve as NIR-excitable luminescent probes, energy donors, and solid supports for bioconjugation. Their anti-Stokes upconversion enables low-autofluorescence readouts in imaging, sensing, and assay development.

  • Bioconjugation chemistry (general):

    • EDC/NHS coupling: Converts surface –COOH to NHS esters that react with primary amines on proteins, peptides, or amino-modified DNA/RNA. Optimal activation in MES, pH 5.0–6.0; coupling at pH 7.2–8.5 (literature).
    • Click-ready routes: Carboxyls can be elaborated to azides/alkynes via linkers for CuAAC or SPAAC; or to maleimides for cysteine-selective conjugation.
    • Polymer grafting: Amide formation with amine-terminated PEG imparts stealth and improved colloidal/biological performance.
  • Sensing & assays (literature): UCNPs act as donors in FRET/LRET with visible emitters/quencher dyes; modulation of emission under NIR excitation supports low-background assays (lateral flow, microbeads, microarrays).

  • Materials integration: Embedding into polymers, hydrogels, or sol–gel matrices creates NIR-readable tags and anti-counterfeiting features; –COOH groups aid covalent incorporation.

  • Microscopy and tracking (research use only): Cellular uptake studies, bead coding, and particle tracking under 980 nm/808 nm excitation. No clinical/diagnostic claims.

  • Practical tips: Ensure colloidal stability prior to coupling (DLS/zeta); avoid primary amine buffers during activation; quench remaining NHS esters (e.g., ethanolamine) after conjugation; remove excess reagents by centrifugation or SEC. All conditions here are general literature guidance; item-specific instructions are Not specified for this SKU.

Reaction Conditions

Item-specific reaction/handling conditions are Not specified; refer to CoA/Spec Sheet. Below are general, literature-based conditions for common transformations on carboxylated UCNPs. Adjust empirically to your system.

  • EDC/NHS amide coupling (aqueous):
    • Disperse UCNPs in MES buffer (50–100 mM, pH 5.0–6.0).
    • Add EDC (e.g., 1–10 mM final) and NHS or sulfo-NHS (2–20 mM) to activate 15–30 min at RT with gentle mixing.
    • Exchange to amine-containing buffer (e.g., phosphate, HEPES, pH 7.2–8.0) and add amine ligand at molar excess relative to estimated surface –COOH (literature often 5–100×). React 1–4 h at RT.
    • Quench residual NHS esters with ethanolamine or Tris; purify by centrifugation, dialysis, or SEC.
  • Characterization checkpoints: DLS/zeta before and after; absorbance/fluorescence spectra to confirm retained upconversion; FTIR/XPS for amide formation.
  • Avoid: Primary-amine buffers during activation; high ionic strength or sudden pH jumps that trigger aggregation; prolonged exposure to strong oxidants/UV that degrade ligands.
  • Alternative coupling: Carbodiimide coupling in mixed aqueous/organic media for hydrophobic amines; or carbonyldiimidazole (CDI) activation in anhydrous solvents if the ligand shell and dispersion permit (literature).

All times/concentrations above are general guidelines from literature and are not specifications for this SKU.

Safety & Handling
  • GHS/CLP status: Not specified for this item; refer to SDS for authoritative hazard classification, H-statements, and pictograms.
  • Signal word/H-statements: Not specified for this item.
  • General nanoparticle precautions (literature/best practice):
    • Avoid inhalation of nanoparticle-containing aerosols and dusts. Handle powders in a fume hood or containment with appropriate HEPA filtration.
    • Wear PPE: lab coat, safety glasses, and suitable gloves (e.g., nitrile). Consider respiratory protection if aerosol generation cannot be controlled.
    • Prevent environmental release; collect nanoparticle waste as solid hazardous waste per institutional policy.
  • Incompatibilities (general): Strong oxidizers can degrade organic surface ligands; strong acids/bases and high ionic strength can induce aggregation or ligand desorption. Fluoride-containing cores are generally stable but may be attacked by hot concentrated bases or complexing agents.
  • First-aid overview (general):
    • Inhalation: Move to fresh air; seek medical attention if symptoms persist.
    • Skin/eye contact: Rinse with water for several minutes; remove contaminated clothing; obtain medical advice if irritation occurs.
    • Ingestion: Rinse mouth; do not induce vomiting; seek medical attention.
  • Spill response: Gently mist to suppress dust; collect with disposable wipes/HEPA vacuum; avoid dry sweeping. Decontaminate surfaces with appropriate wet cleaning.
  • Fire safety: Organic ligands may be combustible; use suitable extinguishing media (CO2, dry chemical, foam). Combustion may generate irritant fumes; firefighters should wear SCBA.
  • Always consult the product’s SDS for definitive instructions.
Solvent Selection

For carboxyl-functionalized UCNPs, solvent/dispersant choice centers on colloidal stability and maintaining reactive –COOH availability.

  • Item-specific solvent preferences: Not specified for this item; refer to CoA/Spec Sheet.
  • General guidance (literature):
    • Aqueous media: –COOH-functionalized surfaces are typically dispersible in deionized water and low-ionic-strength buffers at neutral to slightly basic pH (carboxylates deprotonated). High salt or divalent cations can screen charges and induce aggregation.
    • Activation chemistry: For EDC/NHS coupling, use MES buffer (50–100 mM, pH ~5.0–6.0) to minimize competing amines and maintain O-acylisourea stability (literature). Avoid Tris or buffers containing primary amines during activation/coupling.
    • Organic cosolvents: Small fractions of ethanol/isopropanol can aid wetting or reduce nonspecific adsorption; excessive organic content may collapse the corona and destabilize the colloid.
    • pH considerations: Below pH ~3–4, carboxyls protonate and zeta potential approaches zero, often reducing stability; adjust slowly to avoid shock aggregation.

Comparison (general):

  • Water (DI): maximal charge stabilization; best for storage/handling.
  • MES (pH 5–6): preferred for EDC/NHS activation.
  • PBS (pH 7.4): good for post-conjugation storage but ionic strength may increase aggregation risk for marginally stable systems.

Always test dispersion visually and by DLS before critical steps; filter through low-protein-binding membranes (0.22–0.45 μm) if compatible.

Storage & Reconstitution
  • Storage conditions (item-specific): Storage Conditions: Room temperature (per Product Data). Protect from moisture and excessive light as good practice for nanomaterials with organic ligands. Shipped: Normal.
  • Container/materials: Use clean, airtight containers. Low-protein-binding plastics or silanized glass can reduce adsorption. Avoid prolonged contact with reactive metals.
  • Reconstitution (general):
    • If supplied as a dry solid: Wet surfaces with a minimal volume of ethanol or water, then bring to desired volume with DI water or appropriate buffer. Gentle bath sonication (1–5 min) can aid dispersion. Avoid harsh probe sonication unless necessary.
    • If supplied as a dispersion: Mix by gentle inversion or slow vortex; avoid foaming. Do not freeze unless validated—freeze–thaw cycles can induce aggregation.
  • Working solutions: Prepare fresh as needed. For long experiments, maintain neutral pH and low ionic strength to minimize aggregation. Filter (0.45–0.22 μm) only if compatible with particle size/concentration.
  • Stability/expiry: Not specified for this item; refer to CoA/Spec Sheet for shelf life and any preservative information.
  • Handling tips: Record DLS/zeta before critical steps; avoid amine-containing buffers prior to EDC/NHS activation; store conjugates at 4–25°C per construct stability once validated (not specified for this item).

Always defer to the product’s CoA/SDS for definitive storage, handling, and disposal guidance.

Structure & Identity

Carboxyl-functionalized upconverting nanoparticles (UCNPs) are inorganic photonic nanomaterials whose surfaces present terminal carboxyl (–COOH) groups for downstream coupling and dispersion control.

  • Item-specific identifiers:
    • CAS: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular formula: Not applicable to a discrete molecule; UCNPs are multi-component inorganic nanocrystals with organic surface ligands.
    • Molecular weight: Not applicable to polydisperse nanoparticles.
    • SMILES / InChI / InChIKey: Not applicable to particulate materials; Not specified for this item.
  • Structural features (general, literature):
    • Inorganic core (literature): Often hexagonal β-NaYF4 co-doped with Yb3+ (sensitizer) and Er3+/Tm3+/Ho3+ (emitters) or other fluoride/oxide hosts. Actual composition for this item is Not specified.
    • Surface chemistry: Terminal –COOH groups typically introduced via carboxylated ligands/polymers (e.g., poly(acrylic acid), citrate) enabling covalent coupling to primary amines (EDC/NHS chemistry) and enhancing aqueous dispersibility.
    • Architecture (literature): Can be core or core–shell (e.g., inert NaYF4 shell to improve quantum yield); exact architecture for this item is Not specified.
    • 2D description in words: Spherical (or rod-like) nanoscale crystallites of a lanthanide-doped host lattice surrounded by an organic corona displaying multiple carboxyl termini accessible for bioconjugation or further modification.
  • Optical identity (literature): Exhibit anti-Stokes upconversion—emission of higher-energy photons under NIR excitation (commonly 980 nm via Yb3+ sensitization, or 808 nm when Nd3+ is present). Excitation/emission specifics for this item are Not specified; consult product documentation.
Synthetic Utility

As nanobuilding blocks, carboxyl-functionalized UCNPs provide a versatile platform for surface chemistry rather than acting as traditional small-molecule reagents.

  • Functional handles: Multiple –COOH groups per particle enable formation of amide bonds with primary amines (proteins, polymers, small molecules), creating stable, covalent conjugates.
  • Surface transformation (literature):
    • EDC/NHS activation to NHS esters; subsequent coupling to amines.
    • Carbodiimide coupling to hydrazides to install hydrazone-forming handles for aldehyde/ketone ligation.
    • Conversion of –COOH to acyl chlorides or anhydrides (non-aqueous) for advanced derivatization when colloidally stable in organic media.
    • Grafting of amine-terminated PEG or zwitterions to tune zeta potential, reduce fouling, and modulate spacing to FRET partners.
  • Hybrid architectures: Layer-by-layer assembly with polycations (e.g., PEI) followed by carboxyl reintroduction; silica-coating strategies can add orthogonal silane chemistry while retaining –COOH groups through co-condensation with carboxyl-silanes.
  • Retrosynthetic perspective: Treat the UCNP as a multifunctional, luminescent macro-scaffold; plan linkers to control distance/orientation to fluorophores, quenchers, or binding ligands to optimize FRET/LRET efficiency and binding kinetics.

Note: Item-specific ligand identity/density and solvent compatibility are Not specified; validate coupling stoichiometry and preservation of optical properties for your system.

Target Specificity

Not applicable. This SKU is a nanomaterial and not a biological affinity reagent (e.g., antibody or aptamer). No antigen/epitope, species reactivity, clone, or isotype information applies to this product.

For target-specific applications, users typically conjugate targeting ligands (antibodies, peptides, small molecules) to the –COOH surface via amide coupling (see Reaction & Applications), thereby imparting specificity exogenously. Item-specific targeting data are Not specified for this SKU.

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.